DGAP-Adhoc: Raiffeisen Bank International AG: First Quarter

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

May 22, 2014 at 1:45 AM

DGAP-Adhoc: Raiffeisen Bank International AG: First Quarter Report 2014 and repayment of participation capital

Raiffeisen Bank International AG / Key word(s): Interim Report 22.05.2014 07:32 Dissemination of an Ad hoc announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Following the successful capital increase in the first quarter of 2014, RBI expects to receive approval from the Financial Market Authority (FMA) for full repayment of the participation capital in the near future. As a first step, RBI intends to repay the total amount or at least a substantial part of the state-held tranche. The FMA has notified RBI that the approval will be granted promptly, enabling repayment to take place in the next 3 to 4 weeks. - Net interest income of EUR 979 mn (up 13.2% y-o-y) - Net trading income of minus EUR 19 mn, mainly due to currency-driven valuation losses in Ukraine - General administrative expenses decreased to EUR 755 mn (down 4.2% y-o-y) driven by FX effects - Net provisioning for impairment losses increased to EUR 281 mn (up 28.1% y-o-y) - Profit before tax declined to EUR 240 mn (down 4.3% y-o-y ) - Consolidated profit increased to EUR 161 mn (up 2.5% y-o-y) - NPL ratio decreased to 10.6% (down 0.2PP compared to FY 2013) - NPL coverage ratio increased to 65.2% (up 2.1PP compared to FY 2013) - Common equity tier 1 ratio (transitional) at 13.9% (including participation capital) - Common equity tier 1 ratio (fully loaded) of 9.9% - Leverage ratio of 5.9% comfortably surpasses the 3% envisaged regulatory ratio Income Statement in EUR mn Q1/2014 Q1/2013 Net interest income 979 865 Net provisioning for impairment losses (281) (220) Net interest income after provisioning 697 645 Net fee and commission income 376 375 Net trading income (19) 80 General administrative expenses (755) (788) Net income from derivatives and liabilities (27) (121) Net income from financial investments 37 87 Profit before tax 240 251 Profit after tax 173 174 Consolidated profit 161 157 Balance Sheet in EUR mn 31/03/14 31/12/13 Equity 12,821 10,364 Total assets 125,410 130,640 NPL ratio 10.6% 10.7% NPL coverage ratio 65.2% 63.1% Bank Specific Information 31/03/14 31/12/13 Common equity tier 1 ratio (transitional) 13.9% 10.7% Common equity tier 1 ratio (fully loaded) 9.9% n. a. Performance Q1/2014 Q1/2013 Net interest margin 3.35% 2.89% Return on equity before tax 7.9% 9.2% Return on equity (consolidated) 4.8% 5.6% Cost/income ratio 56.1% 58.5% Earnings per share in EUR 0.41 0.55 Resources 31/03/14 31/12/13 Employees 57,217 57,901 Business outlets 2,991 3,025 The outlook was adapted to the changed environment: We expect loans and advances to customers in 2014 to remain at the approximate level of the previous year. We anticipate a net provisioning requirement of between EUR 1,300 million and EUR 1,400 million in 2014, however, results may be impacted by the ECB Asset Quality Review process and further deterioration of the situation in Ukraine and Russia. In the course of our cost reduction program, we plan to reduce general administrative expenses to below the level of 2012 by 2016. We aim to achieve a cost/income ratio of between 50 to 55 per cent by 2016. Costs in 2014 are expected to be below the level of 2013. We aim for a return on equity before tax of approximately 15 per cent and a consolidated return on equity of approximately 12 per cent in the medium term. For further information please contact: Susanne E. Langer Head of Group Investor Relations Spokesperson Raiffeisen Bank International AG Am Stadtpark 9 1030 Vienna, Austria ir@rbinternational.com phone +43-1-71 707-2089 www.rbinternational.com 22.05.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Raiffeisen Bank International AG Am Stadtpark 9 A-1030 Vienna Austria Phone: +43-1-71707-2089 Fax: +43-1-71707-2138 E-mail: ir@rbinternational.com Internet: www.rbinternational.com ISIN: AT0000606306 WKN: A0D9SU Listed: Wien (Amtlicher Handel / Official Market) End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...